Symptomatic obstructive hypertrophic cardiomyopathy (HCM) causes the heart muscle to thicken, resulting in left ventricular outflow tract obstruction. It is a debilitating condition that can reduce the physical functioning and overall well-being of patients. Despite its global prevalence, there is yet to be an approved first-in-class treatment for obstructive HCM...
EU mavacamten recommendation for obstructive hypertrophic cardiomyopathy
Shrabasti Bhattacharya | Medical News | 28 April 2023
Register or log in to read more
Registration is free and easy, giving you complete access to all Univadis content.Create a Free Account I have an account